Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 1.00 |
| ▸ | RECQL | P46063 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 4/20 | 0.78 |
| ▸ | CDK2 | P24941 | 2/20 | 0.78 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | HTT | P42858 | 4/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.53 |
| ▸ | TP53 | P04637 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.52 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.49 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | BRAF | P15056 | 1/20 | 0.48 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.45 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.45 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 1/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL49690 | 1.00 | TSHR (1.00) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| SCHEMBL25176316 | 1.00 | TSHR (1.00) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| SCHEMBL29412055 | 1.00 | TSHR (1.00) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| SCHEMBL29350488 | 1.00 | TSHR (1.00) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| Hydrochloric Acid SCHEMBL584649 | 0.99 | TSHR (0.97) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| Hydrochloric Acid SCHEMBL27865862 | 0.99 | TSHR (0.97) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| Alcohol SCHEMBL28719125 | 0.97 | TSHR (0.95) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| SCHEMBL30320048 | 0.94 | TSHR (0.88) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| Phosphoric Acid SCHEMBL3301229 | 0.94 | TSHR (0.88) | TSHRRECQLCYP1A2CDK2CYP3A4 | |
| Phosphoric Acid SCHEMBL29264659 | 0.94 | TSHR (0.88) | TSHRRECQLCYP1A2CDK2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 112 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4472642-A1 | HETEROCYCLIC PURINE CYTOKININ DERIVATIVES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | Univerzita Palackého v Olomouci (CZ) | 2024-12-11 | — | — | EP | claimed |
| EP-4153592-B1 | MESYLATE SALTS OF HETEROCYCLIC CYTOKININS, COMPOSITIONS CONTAINING THESE DERIVATIVES AND USE THEREOF | UNIV PALACKEHO (CZ) | 2024-04-24 | — | — | EP | claimed |
| WO-2023078482-A1 | HETEROCYCLIC PURINE CYTOKININ DERIVATIVES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | Univerzita Palackého v Olomouci (CZ) | 2023-05-11 | — | — | WO | claimed |
| EP-0827532-B1 | REGENERATION OF BOTH PLANT TISSUES AND TRANSGENIC PLANT TISSUES USING A NEW PLANT HORMONE, 5-BROMOINDOLE-3-ACETIC ACID | INVITROGEN CORP (US) | 2003-12-10 | — | — | EP | claimed |
| US-5188655-A | Plant growth regulators; synergistic | FLORATINE PRODUCTS GROUP, INC. | 1993-02-23 | — | — | US | claimed |
| EP-4691240-A1 | SUPPLEMENT AND NUTRITIVE SUBSTRATE COMPOSITIONS, SYNTHETIC SEED, METHOD FOR CULTIVATING PLANTS, AND, USE OF A SUPPLEMENT COMPOSITION | CTC - Centro de Tecnologia Canavieira S.A. (BR) | 2026-02-11 | — | — | EP | disclosed |
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | PROCTER & GAMBLE (US) | 2025-12-18 | — | — | US | disclosed |
| EP-4577181-A1 | ORAL CARE COMPOSITIONS | Adyani Consulting Corp. (US) | 2025-07-02 | — | — | EP | disclosed |
| CN-119818548-A | Skin improving composition comprising culture of Parsley | 生物 FD&C 株式会社 | 2025-04-15 | — | — | CN | disclosed |
| EP-4472642-A1 | HETEROCYCLIC PURINE CYTOKININ DERIVATIVES, THEIR USE IN WOUND HEALING AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE DERIVATIVES | Univerzita Palackého v Olomouci (CZ) | 2024-12-11 | — | — | EP | disclosed |
| EP-4384627-A1 | HETEROLOGOUS PRODUCTION OF CYTOKININS IN YEASTS | Adama Chile SA (CL) | 2024-06-19 | — | — | EP | disclosed |
| CN-118202058-A | Heterologous production of cytokinins in yeast | 安道麦智利股份有限公司 | 2024-06-14 | — | — | CN | disclosed |
| WO-2004092345-A2 | TRANSFORMATION OF BRASSICA | CARGILL INCORPORATED (US) | 2004-10-28 | — | — | WO | disclosed |
| WO-2004090143-A2 | MODULATION OF CYTOKININ ACTIVITY IN PLANTS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2004-10-21 | — | — | WO | disclosed |
| US-6617497-B1 | Transformed plant comprising a nucleic acid encoding a protein that exhibits enzymatic activity; can use to alter pathogen resistance and plant growth properties | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2003-09-09 | — | — | US | disclosed |
| EP-1171619-A1 | REGULATED EXPRESSION OF GENES IN PLANT SEEDS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2002-01-16 | — | — | EP | disclosed |
| US-6229066-B1 | AMINO ACID AND NUCLEOTIDE SEQUENCE; TRANSGENIC PLANTS WITH ALTERED PROPERTIES SUCH AS DISEASE RESISTANCE, INCREASED GRAIN PRODUCTION, OR MORE DESIRABLE SECONDARY GROWTH CHARACTERISTICS; RECOMBINANT CULTURE PRODUCTION | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2001-05-08 | — | — | US | disclosed |
| WO-2000063401-A1 | REGULATED EXPRESSION OF GENES IN PLANT SEEDS | PIONEER HI-BRED INTERNATIONAL, INC. (US) | 2000-10-26 | — | — | WO | disclosed |
| EP-1002096-A1 | CYTOKININ OXIDASE | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2000-05-24 | — | — | EP | disclosed |
| WO-1999006571-A1 | CYTOKININ OXIDASE | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 1999-02-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250381110-A1 | SKIN CARE COMPOSITION AND METHOD OF USING THE SAME | SQSTM1, BECN1, CUTA | TSHR 4819/4885RECQL 482/4885CYP1A2 4552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.